{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:39:11Z","timestamp":1767843551860,"version":"3.49.0"},"reference-count":54,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T00:00:00Z","timestamp":1318550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Paediatrics Child Health"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Disadvantaged children of M\u0101ori and Pacific origin in New Zealand carry an inequitable burden of infectious diseases, many of which are preventable, some by vaccine. Immunisation is recognised in the developing world as a cheap, effective and efficient means of reducing inequalities. The MeNZB immunisation programme delivered in 2004\u20132006 towards the expected natural end of a projected 15\u2010year epidemic appears to have had an effect (difficult to prove conclusively) on reducing the disproportionate burden of meningococcal disease carried by this group of children. It was delayed by the late engagement of the New Zealand Ministry of Health, fully briefed from 1996, leading to unnecessary and potentially avoidable deaths and sequelae, many lifelong. Further, failure to adequately assess vaccine effectiveness means that the contribution of MeNZB to the observed reduction in disease, particularly in those aged less than five years, will never be reliably known. However, the MeNZB campaign has at least left a legacy: the National Immunisation Register, which should enable New Zealand to minimise the \u2018vaccine inverse care law\u2019 and contribute to reducing ethnic inequity in the burden of vaccine preventable diseases.<\/jats:p>","DOI":"10.1111\/j.1440-1754.2010.01969.x","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T11:48:36Z","timestamp":1318592916000},"page":"193-201","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic"],"prefix":"10.1111","volume":"48","author":[{"given":"Diana","family":"Lennon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Crengle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teuila","family":"Percival","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,14]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"270","volume-title":"Monitoring the Health of New Zealand Children and Young People: Indicator Handbook","author":"Craig E","year":"2007"},{"key":"e_1_2_6_3_2","volume-title":"NZDep2006 Index of Deprivation","author":"Salmond S","year":"2007"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200010000-00009"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.050"},{"key":"e_1_2_6_6_2","unstructured":"MartinD LopezL McDowellMC eds.The Epidemiology of Meningococcal Disease in New Zealand in 2001. Wellington:The Institute of Environmental Science and Research Ministry of Health 2002."},{"key":"e_1_2_6_7_2","unstructured":"MartinD LopezL McDowellMC eds.The Epidemiology of Meningococcal Disease in New Zealand in 2004. The Institute of Environmental Science and Research Ministry of Health Wellington 2004."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198901000-00004"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37757\/MR2007V9.N1.6","article-title":"Cuban meningococcal BC vaccine: experiences and contributions from 20\u2003years of application","volume":"9","author":"Padron FS","year":"2007","journal-title":"MEDICC Rev."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-148-5:81"},{"key":"e_1_2_6_11_2","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra GV","year":"1991","journal-title":"NIPH Ann."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91961-S"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00037-N"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/26.3.681b"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/iai.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres LG","year":"1994","journal-title":"Infect. Immun."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/24.5.1050"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1327"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.16.1520"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.16.1541"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00044-4"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00320-0"},{"key":"e_1_2_6_22_2","first-page":"617","article-title":"Successful vaccine intervention in a group A meningococcal outbreak in Auckland, New Zealand","volume":"11","author":"Lennon D","year":"1992","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00167-07"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.132571"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.09.043"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000258697.05341.2c"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318195205e"},{"key":"e_1_2_6_28_2","first-page":"57","article-title":"The epidemiology of meningococcal disease in Norway 1975\u201391","volume":"14","author":"Lystad A","year":"1991","journal-title":"NIPH Ann."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/603552"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/656741"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/erv.11.41","article-title":"Meningococcal serogroup B vaccines: will they live up to expectations?","volume":"10","author":"Zollinger WD","journal-title":"Expert Review of Vaccines"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.180596"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.3.5.4458"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.063"},{"key":"e_1_2_6_35_2","unstructured":"JacksonC LennonD WongSet\u2003al. Persistence of Immune Response in New Zealand Adults and Children after 3 doses of MeNZB and response to a 4th Dose in Toddlers. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) September 17\u201320 2007. Chicago United States of America. Poster Presentation. Abstract G\u20101698."},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00591-1"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/508780"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93086-3"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00038-06"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/508776"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/514232"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00047-06"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn228"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm147"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn050"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn051"},{"key":"e_1_2_6_49_2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jama.1993.03500020080036","article-title":"Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination","volume":"269","author":"Murphy TV","year":"1993","journal-title":"J.A.M.A."},{"key":"e_1_2_6_50_2","first-page":"48","article-title":"Delivering a safe and effective strain\u2010specific vaccine to control an epidemic of group B meningococcal disease","volume":"122","author":"O'Hallahan J","year":"2009","journal-title":"N.Z. Med. J."},{"key":"e_1_2_6_51_2","first-page":"110","article-title":"The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic","volume":"121","author":"Lennon D","year":"2008","journal-title":"N.Z. Med. J."},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5459.1816"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199410000-00005"},{"key":"e_1_2_6_54_2","first-page":"351","volume-title":"Immunisation Handbook 2006","author":"Blackmore T","year":"2006"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-009-9451-7"}],"container-title":["Journal of Paediatrics and Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1754.2010.01969.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1754.2010.01969.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:28:36Z","timestamp":1697326116000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1754.2010.01969.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,14]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1111\/j.1440-1754.2010.01969.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1754.2010.01969.x","archive":["Portico"],"relation":{},"ISSN":["1034-4810","1440-1754"],"issn-type":[{"value":"1034-4810","type":"print"},{"value":"1440-1754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,14]]},"assertion":[{"value":"2011-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}